Black Hawk Acquisition Corporation Announces Redemption Results in Connection With Its Business Combination With Vesicor Therapeutics Inc.

BLACKHAWK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Black Hawk Acquisition Corporation (NASDAQ: “BKHAU,” “BKHA,” “BKHAR”) “Black Hawk” or the “Company”) today announced that, in connection with its proposed business combination (the “Business Combination”) with Vesicor Therapeutics Inc. (“Vesicor”), holders of 2,089,162 Class A ordinary shares eligible for redemption exercised their redemption rights, resulting in aggregate redemption payments of approximately $25.15 million. The redemptions relate solely to shares eligible for redemption and do not affect the Company's other issued and outstanding Class A ordinary shares. Following the redemptions, the Company is expected to have approximately 2.06 million Class A ordinary shares issued and outstanding, including shares not subject to redemption. Based on the redemption elections, approximately $420,377 is estimated to remain in the Company's trust account, subject to final reconciliation and adjustment.